Drugs / endothelial outgrowth cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02975518 | Dec 2015 → Mar 2018 | coronary artery disorder | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | endothelial outgrowth cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02975518 ↗ |
| Modality | Cell therapy | “endothelial progenitor cell (EPC) product” NCT02975518 ↗ |
| Route | Intravenous | “administered intra-venously” NCT02975518 ↗ |